Abingworth

company

Investments

Number of Investments
Number of Lead Investments
13
2
Abingworth has made 13 investments. Their most recent investment was on Dec 6, 2022, when Entact Bio, Inc raised
Date Company Name Round Money Raised Industry Lead Investor
Dec 6, 2022 Entact Bio Series A Biopharma
Apr 19, 2021 Adaptate Biotherapeutics Series A Biotechnology
Mar 19, 2021 X4 Pharmaceuticals Post-IPO Equity Biotechnology
Jan 7, 2021 Scorpion Therapeutics Series B Biotechnology
Oct 26, 2020 Scorpion Therapeutics Series A Biotechnology
Jan 13, 2015 Personalis Series C Biotechnology
May 16, 2014 Proteon Therapeutics Series D Biotechnology Yes
Oct 7, 2013 Personalis Series B Biotechnology Yes
Jan 8, 2013 Labcyte Series D Alternative Medicine
Aug 15, 2011 Personalis Series A Biotechnology
Mar 26, 2008 Labcyte Series C Alternative Medicine
Jul 25, 2005 Labcyte Series C Alternative Medicine
Jul 9, 2002 Labcyte Series B Alternative Medicine